British healthcare body recommends Thrombogenics drug
BRUSSELS (Reuters) - Belgian biotech group Thrombogenics said on Wednesday that it received a positive initial recommendation from B...
Read More »BRUSSELS (Reuters) - Belgian biotech group Thrombogenics said on Wednesday that it received a positive initial recommendation from B...
Read More »
By Kate Kelland LONDON (Reuters) - The outlawing of drugs such as cannabis, magic mushrooms and other psychoactive substances amount...
Read More »LONDON (Reuters) - GlaxoSmithKline has finally won a green light from Britain's healthcare cost agency NICE for its platelet-boostin...
Read More »By Joseph Ax NEW YORK (Reuters) - New York City lawyers tried to convince an appeals court on Tuesday to allow Mayor Michael Bloombe...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Pregnant women who are overweight or obese are more likely to give birth prematurely,...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - A one-hour educational session followed by personalized feedback helped pediatricians...
Read More »
By Carey Gillam (Reuters) - Pigs fed a diet of only genetically modified grain showed markedly higher stomach inflammation than pigs...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - After years on the rise, the number of CT scans performed on kids every year seems to...
Read More »NEW YORK (Reuters) - Royalty Pharma, pursuing a hostile $8 billion takeover of Irish drugmaker Elan Corp Plc, moved on Tuesday to ma...
Read More »
By Jonathan Stempel and Jessica Wohl (Reuters) - Walgreen Co, the largest U.S. drugstore chain, has agreed to pay $80 million in civ...
Read More »